Ria Schlichter
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.
Journal: Molecular medicine (Cambridge, Mass.)
Published: December 16, 2025
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.
Journal: Virchows Archiv : an international journal of pathology
Published: November 04, 2025
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.
Journal: Experimental and molecular pathology
Published: July 23, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotype.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 11, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.
Journal: PloS one
Published: December 11, 2024
Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entities.
Journal: Human pathology
Published: December 02, 2024
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: November 29, 2024
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors.
Journal: Virchows Archiv : an international journal of pathology
Published: November 22, 2024
Last Updated: 09/26/2026